Aligos Therapeutics Inc (NASDAQ:ALGS)

Delayed Data
As of Jun 02
 -0.03 / -2.52%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Aligos Therapeutics Inc have a median target of 4.50, with a high estimate of 7.00 and a low estimate of 2.00. The median estimate represents a +287.93% increase from the last price of 1.16.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Aligos Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.60%
Growthannually 18.89%


Growthquarterly -100.00%
Growthannually -80.59%
Key to the earnings and sales forecast charts.